Christian Fletcher is an established Atlanta entrepreneur who leads the accredited testing lab LifeBrite Laboratories and delivers analytical solutions in molecular pathology and toxicology. As explored in a LifeBrite Laboratories blog article, Christian Fletcher’s company emphasizes the continued importance of COVID-19 testing, even as eligibility for vaccines broadens.
With the number of doses administered approaching 200 million, there are still fundamental issues of unpredictability in vaccines and threats posed by emerging COVID-19 strains. FDA-approved vaccines’ efficacy rates are in the 72 to 95 percent range, making it possible for those who are vaccinated to contract the virus. Vaccinated people can still exhibit symptoms of COVID-19 and be placed at risk when coming into contact with someone who has the condition. Another issue is that vaccine eligibility does not always mean that the vaccine can be readily obtained. It can take several weeks for eligible populations to get fully vaccinated. Another compelling reason for routine testing centers on the epidemiological resource it provides disease experts. Tests give actionable insights into reasons for isolated outbreaks within certain communities. The bottom line is that, regardless of whether the patient has accessed a vaccine, testing can be vitally important.
0 Comments
Leave a Reply. |
AuthorLifeBrite Laboratories Head Administrator Christian Fletcher. ArchivesCategories |